BE0003818359
BE0003818359
LAKEFRONT BIOTHERAPEUTICS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.72B EUR | 1.72B EUR | 1.73B EUR | 1.85B EUR |
Enterprise Value | -505.14M EUR | 1.59B EUR | 1.66B EUR | 1.76B EUR |
Valuation Multiples | ||||
Trailing P/E | 2.92x | 2.89x | 3.53x | 3.89x |
Forward P/E | -5.32x | -- | -- | -- |
Price to Sales | 1.74x | 1.74x | 1.65x | 1.78x |
Price to Book | 0.53x | 0.53x | 0.53x | 0.57x |
EV/Revenue | -0.51x | 1.61x | 1.6x | 1.7x |
EV/EBITDA | -0.89x | 2.41x | 2.92x | 2.53x |
Price to FCF (P/FCF) | 12.47x | -- | -- | -- |
EV/FCF | -3.65x | -- | -- | -- |
FCF Yield | 8.02% | -13.45% | -17.99% | -12.33% |